Many people haven’t heard of Barrett’s Esophagus, but it’s a serious condition that can be a warning sign for a deadly cancer ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

Castle Biosciences, Inc, a leading diagnostics company improving health through innovative tests that guide patient care, announced it has signed a definitive agreement to acquire Capsulomics, Inc, ...

From acid reflux to immune reactions, esophagitis has many causes—learn about its symptoms, types, and the latest treatments ...

Castle Biosciences has signed an agreement to acquire GI health company Previse, which was developed by specialists at Johns Hopkins University School of Medicine in Baltimore. Previse is focused on ...

1) Poster Su1466: The Tissue Systems Pathology Test Detected Presence of Missed Neoplasia in a Patient with Non-Dysplastic Barrett’s Esophagus Presenter and Lead Author: Philip Woodworth ...

CDx Diagnostics announced today that new clinical data supporting the utility of the WATS3D test for Barrett's esophagus and dysplasia screening and surveillance has been selected for podium ...

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled,“The ...

risk stratification in patients with and without a family history of Barrett's esophagus and/or esophageal cancer Presenter: Marcia (Mimi) Canto, M.D., MHS, professor of medicine at The Johns ...